Release Date: 09/02/09 17:57 Summary: Response to ASX Query re Appendix 4C Price Sensitive: No Download Document 206.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%